The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreas

American Journal of Gastroenterology

Volumn 95, Issue 7, 2000, Pages 1708-1713

  Tierney, William M ^a   Fendrick, A Mark ^a,b   Hirth, Richard A ^b,c   Scheiman, James M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Innov Cost effectiveness S ^*  (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; HOSPITALIZATION; HUMAN; OUTCOMES RESEARCH; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REIMBURSEMENT;

ADENOCARCINOMA; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HUMANS; LAPAROSCOPY; NEOPLASM STAGING; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0033915522     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00983-7     Document Type: Article

References (43)

1. Parker S.L., Tong T., Bolden S., et al. Cancer statistics, 1996. CA Cancer J Clin. 65:1996;5-27.
2. Connolly M.M., Dawson P.J., Michelassi F., et al. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg. 206:1987;366-370.
3. Trede M. The surgical treatment of pancreatic carcinoma. Surgery. 97:1985;28-35.
4. Rosenberg J.M., Welch J.P., Macaulay W.P. Cancer of the head of the pancreas An institutional review with emphasis on surgical therapy . J Surg Oncol. 28:1985;217-221.
5. Tsuchiya R., Noda T., Harada N., et al. Collective review of small carcinomas of the pancreas. Ann Surg. 203:1986;77-81.
6. Bakkevold K.E., Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery Risk factors influencing the short-term results . Ann Surg. 217:1993;358-368.
7. Gudjonsson B. Cancer of the pancreas 50 Years of surgery . Cancer. 60:1987;2284-2303.
8. Nagakawa T., Nagamori M., Futakami F., et al. Results of extensive surgery for pancreatic carcinoma. Cancer. 77:1996;640-645.
9. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas 201 Patients . Ann Surg. 221:1995;721-733.
10. Trede M., Schwall G., Saeger H. Survival after pancreatoduodenectomy 118 Consecutive resections without an operative mortality . Ann Surg. 211:1990;447-458.
11. Cameron J.L., Crist D.W., Sitzmann J.V., et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 161:1991;120-125.
12. Ettinghausen S.E., Schwartzentruber D.J., Sindelar W.F. Evolving strategies for the treatment of adenocarcinoma of the pancreas. J Clin Gastroenterol. 21:1995;48-60.
13. Gudjonsson B., Livstone E.M., Spiro H.M. Cancer of the pancreas Diagnostic accuracy and survival statistics . Cancer. 42:1978;2494-2506.
14. Watanapa P., Williamson R.C.N. Surgical palliation for pancreatic cancer Developments during the past two decades . Br J Surg. 79:1992;8-20.
15. Lillemoe K.D., Sauter P.K., Pitt H.A., et al. Current status of surgical palliation of periampullary carcinoma. Surg Gynecol Obstet. 176:1993;1-10.
16. Smith A.C., Dowsett J.F., Russell R.C.G., et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet. 344:1994;1655-1660.
17. Andersen J.R., Sorensen S.M., Kruse A., et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 30:1989;1132-1135.
18. Shepherd H.A., Royle G., Ross A.P.R., et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct A randomized trial . Br J Surg. 75:1988;1166-1168.
19. Siegel J.H., Snady H. The significance of endoscopically placed prostheses in the management of biliary obstruction due to carcinoma of the pancreas Results of nonoperative decompression in 277 patients . Am J Gastroenterol. 81:1986;634-641.
20. Freeny P.C., Marks W.M., Ryan J.A., et al. Pancreatic ductal adenocarcinoma Diagnosis and staging with dynamic CT . Radiology. 166:1988;125-133.
21. Warshaw A.L., Tepper J.E., Shipley W.U. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg. 151:1985;76-80.
22. Warshaw A.L., Gu Z., Wittenberg J., et al. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg. 125:1990;230-233.
23. Castillo C.F., Rattner D.W., Warshaw A.L. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg. 82:1995;1127-1129.
24. John T.G., Greig J.D., Carter D.C., et al. Carcinoma of the pancreatic head and periampullary region Tumor staging with laparoscopy and laparoscopic ultrasonography . Ann Surg. 221:1995;156-164.
25. Bemelman W.A., DeWit L.T., Van Delden O.M., et al. Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region. Br J Surg. 82:1995;820-824.
26. Mackie C.R., Noble H.G., Cooper M.J., et al. Prospective evaluation of angiography in the diagnosis and management of patients suspected of having pancreatic cancer. Ann Surg. 189:1979;11-17.
27. Howard T.J., Chin A.C., Strieb E.W., et al. Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg. 174:1997;237-241.
28. Murugiah M., Windsor J.A., Redhead D.N., et al. The role of selective visceral angiography in the management of pancreatic and periampullary cancer. World J Surg. 17:1993;796-800.
29. Appleton G.V.N., Bathurst N.C.G., Virjee J., et al. The value of angiography in the surgical management of pancreatic disease. Ann R Coll Surg Engl. 71:1989;92-96.
30. Hemmigsson A., Jacobson G., Lindgren P.G., et al. Radiologic assessment of resectability of carcinoma of the head of the pancreas. Acta Radiol Diagnosis. 23:1982;127-130.
31. Jafri S.Z., Aisen A.M., Glazer G.M., et al. Comparison of CT and angiography in assessing resectability of pancreatic carcinoma. AJR. 142:1984;525-529.
32. Snady H., Bruckner H., Siegel J., et al. Endoscopic ultrasound criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointest Endosc. 40:1994;326-333.
33. Rosch T., Braig C., Gain T., et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Gastroenterology. 102:1992;188-199.
34. Tio T.L., Tytgat G.N., Cikot R.J., et al. Ampullopancreatic carcinoma Preoperative TNM classification with endosonography . Radiology. 175:1990;455-461.
35. Palazzo L., Roseau G., Gayet B., et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Endoscopy. 25:1993;143-150.
36. Nakaizumi A, Uehara H, Iishi H, et al. Endoscopic ultrasound in diagnosis and staging of pancreatic cancer. Dig Dis Sci 1995;40:696-70.
37. Muller M.F., Meyenberger C., Bertschinger P., et al. Pancreatic tumors Evaluation with endoscopic US, CT, and MR imaging . Radiology. 190:1994;745-751.
38. Giovanni M., Steitz J.F. Endoscopic ultrasound with linear-type echoendoscope in the evaluation of 94 patients with pancreaticobiliary disease. Endoscopy. 26:1994;579-585.
39. Brugge W.R., Lee M.J., Kelsey P.B., et al. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc. 43:1996;561-567.
40. Hiroki T., Hauptmann E., Traverso L., et al. How accurate is helical computed tomography for clinical staging of pancreatic cancer. Am J Surg. 177:1999;428-432.
41. Cameron J.L. The current management of carcinoma of the head of the pancreas. Annu Rev Med. 46:1995;361-370.
42. Tierney W.M., Carpenter S.L., Bansal R., et al. Accuracy and economic impact of helical CT and endoscopic ultrasound in the staging of ampullopancreatic tumors. Gastrointest Endosc. 45:1997;AB183.
43. Gress F., Ciaccia D., Kiel J., et al. Endoscopic ultrasound versus sprial computed tomography for staging pancreatic, biliary and ampulary tumors A prospective comparison . Gastroeintest Endosc. 45:1997;AB173.